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Abstract
Purpose Quality of life may predict survival. In addition to
clinical variables, it may be influenced by psychological fac-
tors, some of which may be accessible for intervention. The
primary objective of this study was to investigate the associ-
ation of intrusive thoughts and the patients’ sense of coherence
with pretreatment quality of life in patients with newly diag-
nosed rectal cancer.
Methods Patients were prospectively included in 16 hospitals
in Sweden and Denmark. They answered an extensive ques-
tionnaire after receiving their treatment plan. Clinical data
were retrieved from national quality registries for rectal
cancer.
Results Of 1248 included patients, a total of 1085 were
evaluable. Pretreatment global health-related and overall qual-
ity of life was lower in patients planned for palliative com-
pared with curative treatment (median 53 vs. 80 on the
EuroQoL visual analogue scale, p < 0.001 and odds ratio
0.56, 95% confidence interval 0.36–0.88, respectively).
Quality of life was associated with intrusive thoughts (odds
ratio 0.33, 95% confidence interval 0.24–0.45) and sense of
coherence (odds ratio 0.44, 95% confidence interval 0.37–
0.52) irrespective of the treatment plan.
Conclusions Pretreatment quality of life was influenced by
the intent of treatment as well as by intrusive thoughts and
the patients’ sense of coherence. Interventions could modify
these psychological factors, and future studies should focus on
initiatives to improve quality of life for this group of patients.
Keywords Cancer . Oncology . Rectal cancer . Quality of
life . Intrusive thoughts . Sense of coherence . Clinical trial
Introduction
Rectal cancer is potentially life threatening. Curative treatment
is attempted in about 80% while remaining patients receive
palliative treatment [17]. Survival has improved in recent
years, and consequently, quality of life (QoL) has received
increasing attention [1]. Interestingly, several studies have
found QoL to be predictive of survival in patients with cancer
[9, 25, 31]. Furthermore, one study has demonstrated the
prognostic significance of pretreatment QoL for survival in
primary rectal cancer [8]. Several factors may influence pre-
treatment QoL in patients with newly diagnosed rectal cancer,
including the cancer disease per se [12]. QoL could be influ-
enced by the treatment plan, i.e., curative or palliative intent
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and the type of surgical procedure planned. Several studies
have found QoL to be associated with psychological and per-
sonality trait variables independent of clinical factors [13, 27,
32, 33]. Cancer-related intrusive thoughts, i.e., unintentional
recurrent or distressing thoughts about cancer, are among the
more prominent stress-related symptoms experienced by pa-
tients with cancer [15, 30]. An association has been reported
between intrusive thoughts and QoL in patients with prostate
cancer [37, 41], but this has not been studied in patients with
rectal cancer. Another psychological variable that may be as-
sociated with QoL is sense of coherence (SOC), which reflects
a person’s view on life and capacity to respond to stressful
situations [2, 10]. Sense of coherence was developed by
Aaron Antonovsky in the 1970s [2] and may be regarded as
a test of personality traits or coping disposition. It mirrors the
extent to which we perceive life as comprehensible, manage-
able, and meaningful [24]. An association between sense of
coherence and quality of life has been reported in several
studies [10].
We hypothesized that pretreatment quality of life is influ-
enced by psychological factors irrespective of clinical variables
like intent of treatment. The primary objective of the present
analysis was to investigate the association of intrusive thoughts
and the patients’ sense of coherence with pretreatment quality
of life in patients with newly diagnosed rectal cancer.
Methods
Study design
TheQoLiRECTstudy is an ongoing prospective observational
multicenter study of quality of life and functional outcome in
patients with rectal cancer [3]. All patients aged above 18 years
with a biopsy-confirmed rectal adenocarcinoma were eligible
for inclusion, regardless of tumor stage or planned treatment.
The only exclusion criterion was inability to understand and
respond to the questionnaire due to language difficulties or to
cognitive failure. Inclusion began in February 2012 and was
terminated in September 2015 and took place when the diag-
nostic work-up was complete and the patient had been pre-
sented with a treatment plan, but before treatment had started.
Informed consent was obtained from all included patients.
Patients will be followed for 5 years with data collection at
baseline as well as 1, 2, and 5 years after inclusion. The pres-
ent analysis is concerned with baseline pretreatment data only.
Data collection
At inclusion, patients completed a comprehensive pretreat-
ment questionnaire which included questions on overall
QoL and global health-related QoL, intrusive thoughts, and
sense of coherence. Patients were contacted by the study
secretariat by phone within a few days after inclusion and
received the questionnaire bymail. In hospitals with short lead
times to start of treatment, the questionnaire was handed to the
patient at inclusion and was returned to the study secretariat by
prepaid envelope. Questionnaires were returned to the secre-
tariat before treatment was initiated.
At inclusion, patients were registered as candidates for ei-
ther curative or palliative treatment. For curative patients, it
was indicated whether the treatment plan included an
abdominoperineal excision (APE) or not. This information
was registered in a database at the study secretariat along with
name, address, and other basic personal data needed for logis-
tic reasons. All other clinical data, including pretreatment
staging, were collected from the national quality registries
(the Swedish ColoRectal Cancer Registry [26] and the nation-
al database of the Danish Colorectal Cancer Group [14]) or
hospital administrative systems.
Questionnaire development
The development of the study specific questionnaire has been
described in detail elsewhere [3]. The questionnaire was de-
veloped according to a well-established method [18, 36] in-
cluding semi-structured interviews with patients followed by
construction of questions and subsequent content and face-to-
face validation. It was forward and backward translated into
Danish and then face-to-face validated once more as previous-
ly described [3]. Parts of the questionnaire have been used
previously in a cross-sectional Swedish national study of pa-
tients with rectal cancer treated with abdominoperineal exci-
sion [4]. The questionnaire included novel questions specific
for rectal cancer as well as questions previously used in pa-
tients with urological and gynecological cancer [6, 36, 38].
Also included was the EQ-5D-3L [7] as well as questions on
cancer-related intrusive thoughts [37] and the 29-item Sense
of Coherence scale (SOC-29) [2], a validated and cross-
culturally applicable instrument to measure sense of coher-
ence [11].
Outcome measures
Overall QoL was assessed by the question BHow would you
describe your quality of life during the past month?^ with a
seven-point Likert scale response format anchored by zero
(BNo quality of life^) and six (BBest possible quality of life^).
Global health-related QoL was assessed by the EQ-5D-3L
visual analogue scale [7, 29], anchored by 0 (worst imaginable
health state) and 100 (the best imaginable health state).
Explanatory variables
Cancer-related intrusive thoughts were assessed by two ques-
tions pertaining to the frequency and severity of intrusions:
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BHow often during the past month have you had negative
thoughts about your rectal cancer, suddenly and unintention-
ally?^, assessed by an ordinal scale with seven levels ranging
from BNever^ to BMore than 3 times per day or all the time,^
and BHow intrusive have you experienced the sudden negative
thoughts about your rectal cancer?^, with response options
BNot at all intrusive,^ BA little bit intrusive,^ BModerately
intrusive,^ and BVery intrusive^ as well as BNot applicable.^
These variables were dichotomized for the analysis as ex-
plained in the corresponding tables.
Sense of coherence [2] was evaluated by SOC-29, which
consists of 29 items and three domains: 11 comprehensibility
items (e.g., BDo you have the feeling that you are in an unfa-
miliar situation and don’t knowwhat to do?^), 10manageabil-
ity items (e.g., BHow often do you have feelings that you are
not sure you can keep under control?^), and eight meaning-
fulness items (e.g., BDo you have the feeling that you don’t
really care about what goes on around you?^). Each item is
assessed by a seven-point Likert scale, and items are summat-
ed into a total score that ranges from 29 to 203.
The third explanatory variable was the treatment plan
which was either curative or palliative. Patients planned for
curative treatment were further subgrouped as candidates for
APE with a permanent stoma, or other curative procedures.
Possible confounders
Comorbidity was characterized by a number of health condi-
tions, including joint disorders, cardiovascular, neurologic,
pulmonary, renal, bowel and psychological conditions as well
as diabetes and chronic pain, and defined as the presence of at
least one of these conditions. Depression was treated as a
separate confounder and was evaluated by a validated
single-item question [34]. Age, sex, marital status, education,
occupation, and time from diagnosis were also adjusted for in
the statistical analysis as well as whether the patient consid-
ered him or herself well informed about the cancer and the
planned treatment.
External validity
Selection bias was evaluated by comparing included and non-
included patients at participating departments of surgery dur-
ing the inclusion period (Fig. 1). Data were retrieved on sex,
age, ASA (American Society of Anesthesiologists) grade,
clinical TNM status, and tumor height from the national qual-
ity registries [14, 26] and hospital administrative systems.
Population normative data
A representative cohort of 3000 Swedish men and women
born 1924–1983 was randomly selected from the general pop-
ulation through the Swedish Tax Agency and contacted by
letter and telephone (Fig. 2). A total of 1078 persons (median
age 63 years, range 31–90; 53% female) accepted to partici-
pate and completed a questionnaire similar to the study ques-
tionnaire. This allowed for comparison of results to the popu-
lation norm.
Statistical analysis
A detailed statistical plan was developed prior to data analysis.
A proportional odds model [22] was used to explore the asso-
ciation of overall QoL (BHowwould you describe your quality
of life during the past month?^) and the explanatory variables.
Results were presented as odds ratios with 95% confidence
intervals. A confidence interval covering one was considered
non-significant. Adjusted analyses were performed with the
potential confounders included as covariates. Although over-
all quality of life was dichotomized in Table 5 as done previ-
ously [36, 37], the odds ratios are based on the original
(continuous) seven-point Likert scale. The impact of the ex-
planatory variables on global health-related QoL (EQ-5D-3L
visual analogue scale) was analyzed using Mann-Whitney test
and Spearman’s rank correlation.
In the calculation of the SOC-29 total sum score, missing
values in 25% or less of the items were replaced by the median
score for the remaining answered items. If more than 25% of
1248 patients were included in the study
Did not complete questionnaire, n=131
1085 patients were included in the analysis 
1216 patients
Exclusion of centre due to poor inclusion, n=32
Not included, n=2242
3490 patients were registered in the Swedish 
and Danish quality registries by participating 
centres during the study period
Fig. 1 Flowchart of patients.
Non-included patients (n = 2242)
did not meet the inclusion criteria
or were missed to inclusion
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the items had missing values, the total score was regarded as
missing.
Statistical analyses were performed using SPSS 21.0 (IBM
SPSS Inc. Armonk, NY, USA) and SAS v. 9 (SAS institute).
Appropriate permission was obtained from the Danish
Data Protection Agency (HEH.750.89-21; HGH-2016-016)
and the Regional Ethical Review Board in Sweden (EPN
595-11) and Denmark (H-3-2012-FSP26). Permissions to
use SOC-29 and EQ-5D-3L were also obtained. The study
was registered at ClinicalTrials.gov (NCT01477229).
Results
Between February 2012 and September 2015, 16 departments
of surgery in Sweden and Denmark prospectively included
1248 patients with newly diagnosed rectal cancer, of which
1085 patients were available for analysis (Fig. 1). There were
no significant differences regarding patient demographics be-
tween patients to be treated with curative or palliative intent
(Table 1) or any clinically relevant differences regarding age,
sex, or tumor height between these groups (Table 2), but as
3000 persons were identified through the Swedish 
Tax Agency 
An introductory letter was sent to 2955 persons, 
1636 of which we were subsequently able to contact 
by telephone
Diseased, n=44
Confidential address, n=1
No consent, n=680
Unable (mentally or physically) to participate, n=133
Emigrated, n=18
Excluded, various reasons, n=30
1078 persons returned the questionnaire and were 
included in the analysis
A questionnaire was sent to 2094 persons who gave 
oral consent by telephone (n=775) or were 
unreachable by telephone (n=1319) Oral consent by telephone, did not return the 
questionnaire, n=130
Unreachable by telephone, did not return the 
questionnaire, n= 886
Fig. 2 Flowchart of persons
included in the reference
population sample
Table 1 Demography of the
study group All, n = 1085 Curative, n = 1012 Palliative, n = 73 p value Missing
Marital status (%) n.s. 11
In a relationship 796 (74) 747 (75) 49 (68)
Not in a relationship 278 (26) 255 (25) 23 (32)
Education (%) n.s. 19
University 198 (19) 189 (19) 9 (13)
No university 868 (81) 806 (81) 62 (87)
Occupation (%) n.s. 17
Working 311 (29) 292 (29) 19 (26)
Retired 692 (65) 645 (65) 47 (65)
Unemployed 14 (1) 14 (1) 0 (0)
Sick leave 51 (5) 45 (5) 6 (8)
Comorbidity (%) n.s. 84
Yes 661 (61) 610 (61) 51 (70)
No 412 (38) 390 (39) 22 (30)
Depression (%) n.s. 9
Yes/do not know 181 (17) 165 (16) 16 (22)
No (%) 895 (83) 839 (84) 56 (78)
Time since diagnosis (%) n.s. 24
0–1 week 165 (16) 152 (15) 13 (18)
1–2 weeks 192 (18) 180 (18) 12 (17)
2–4 weeks 405 (38) 377 (38) 28 (38)
> 4 weeks 299 (28) 279 (28) 20 (27)
n.s. = p value > 0.05
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expected, the tumor stage differed. The distribution of sex,
age, ASA grade, and clinical tumor stage differed significantly
between patients included in the study and non-included pa-
tients (Table 3).
In the study group, intrusive thoughts were frequent among
all patients without any significant differences between pa-
tients planned for curative and palliative treatment (Table 4).
Sense of coherence differed slightly between groups (Table 4).
Patients planned for palliative treatment assessed their
overall QoL and global health-related QoL as lower than pa-
tients with a curative treatment plan (Table 5). Patients with a
curative treatment plan had similar global health-related QoL
as a general population, but significantly lower overall QoL
(data not shown). Patients planned for APE reported lower
overall QoL, but not lower global health-related QoL, com-
pared with patients planned for other types of curative treat-
ment (Table 5). The experience of intrusive thoughts was as-
sociated with lower overall QoL and global health-related
QoL. The higher the frequency and perceived intrusiveness
of these thoughts, the greater was the impact on QoL
(Table 5). A 25-unit increase in the total score of SOC-29
was associated with better overall QoL (odds ratio 0.44,
95% confidence interval 0.37–0.52), and sense of coherence
was positively correlated with global health-related QoL
(Spearman correlation 0.44; p < 0.001).
A total of 97% of the patients planned for curative treat-
ment considered themselves well informed about their diag-
nosis and treatment plan vs. 85% of the patients planned for
palliative treatment, (p < 0.001).
Discussion and conclusions
In the present study, we found that QoL was lower in patients
planned for palliative compared with curative treatment.
Patients with potentially curable disease had a global health-
related QoL comparable to that of a general population, but a
significantly lower overall QoL. It is important to note that
low QoL was associated with the experience of intrusive
thoughts, a possibly modifiable factor. QoL was also associ-
ated with sense of coherence, a personal trait factor.
The physical effects of the disease burden as well as the
psychological reaction to the palliative situation may partly
explain the low QoL in patients planned for palliative treat-
ment. One such reaction is intrusive thoughts which may be
modified by expressive writing, cognitive behavioral therapy,
Table 2 Clinical characteristics
of the study group All Curative Palliative p
valuec
All Not APE APE
Number of patients 1085 1012 740 272 73
Sex (%) n.s.
Female 490 (45) 460 (45) 331 (45) 129 (47) 30 (41)
Male 595 (55) 552 (55) 409 (55) 143 (53) 43 (59)
Age, median (range) 69 (25–100) 69 (25–100) 68 (25–100) 70 (38–91) 70 (35–96) < 0.05
Tumor stage, cTNMa (%)
T1–T2 269 (25) 268 (26) 199 (27) 69 (25) 1 (1) < 0.001
T3 559 (51) 525 (52) 399 (54) 126 (46) 34 (47)
T4 158 (15) 128 (13) 74 (10) 54 (20) 30 (41)
TX 99 (9) 91 (9) 68 (9) 23 (9) 8 (11)
N0 426 (39) 416 (41) 306 (41) 110 (40) 10 (14) < 0.001
N1–N2 532 (49) 484 (48) 352 (48) 132 (49) 48 (66)
NX 127 (12) 112 (11) 82 (11) 30 (11) 15 (20)
M0 894 (82) 877 (87) 639 (87) 238 (87) 17 (23) < 0.001
M1 124 (12) 77 (7) 61 (8) 16 (6) 47 (64)
MX 67 (6) 58 (6) 40 (5) 18 (7) 9 (12)
Tumor heightb,
median (range)
8 (0–15;
IQR 6)
8 (0–15;
IQR 6)
10 (0–15;
IQR 4)
4 (0–15;
IQR 3)
9 (2–15;
IQR 7)
n.s.
n.s. = p value > 0.05
a Clinical TNM stage, based on radiology
bMeasured in centimeters from the anal verge on retraction of a rigid rectoscope in the left lateral position. Data
missing in 64 patients
c Curative vs. palliative patients
Int J Colorectal Dis (2017) 32:1639–1647 1643
and pharmacological interventions [19, 23]. Although previ-
ously thought to be intrinsic and non-modifiable, recent
preliminary data have indicated that sense of coherence may
indeed be strengthened by psychotherapy [16].
Table 4 Distribution of
psychological explanatory
variables among patients planned
for curative and palliative
treatment
All, n = 1085 Curative,
n = 1012
Palliative, n = 73 p
value
Missing
Sense of coherence, mean
(SD; range)
158 (20; 85–203) 159 (20; 85–203) 153 (22; 98–196) < 0.05 29
Intrusive thoughts (%) n.s. 16
No 184 (17) 170 (17) 14 (19)
Yes 885 (83) 826 (83) 59 (81)
Frequency (%) n.s. 16
Lowa 271 (31) 254 (31) 17 (29)
Higha 614 (69) 572 (69) 42 (71)
Intrusiveness (%) n.s. 62
Lowb 551 (67) 516 (67) 35 (65)
Highb 272 (33) 253 (33) 19 (35)
n.s. = p value > 0.05
a Less than once per week/at least once per week
b Less than moderately intrusive/moderately or very intrusive
Table 3 Comparison between
the study group and the non-
included patients
Study group Non-includeda p value
Number of patients 1085 2242
Sex (%) < 0.001
Female 490 (45) 882 (39)
Male 595 (55) 1360 (61)
Age, median (range) 69 (25–100) 70 (23–100) < 0.001
ASA gradeb (%) < 0.001
1 230 (24.5) 394 (22)
2 560 (60) 982 (54)
3 142 (15) 404 (22)
4 5 (0.5) 28 (2)
Tumor stage, cTNMc (%)
T1–T2 269 (25) 484 (22) < 0.001
T3 559 (51) 936 (42)
T4 158 (15) 475 (21)
TX 99 (9) 347 (15)
N0 426 (39) 420 (19) < 0.001
N1–N2 532 (49) 742 (33)
NX 127 (12) 1080 (48)
M0 894 (82) 1749 (78) < 0.001
M1 124 (12) 408 (18)
MX 67 (6) 85 (4)
Tumor heightd, median (range) 8 (0–15; IQR 6) 8 (0–15; IQR 6) n.s.
n.s. = p value > 0.05
a Patients treated at participating hospitals during the inclusion period but not included in the study
bASA (American Society of Anesthesiologists) grade is missing in patients scheduled for palliative treatment
c Clinical TNM stage, based on radiology
dMeasured in centimeters from the anal verge on retraction of a rigid rectoscope in the left lateral position. Data
were missing in 64 patients in the study group and in 55 non-included patients
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There were no clinically relevant differences of overall
QoL or global health-related QoL between patients planned
for curative treatment with APE vs. other curative procedures
[29]. In view of the fact that 97% of the curative patients felt
well informed about their treatment, this indicates that patients
received adequate supportive care when presented with their
treatment plan, including patients scheduled for a permanent
stoma. As recently reported, Swedish patients’ QoL was not
limited by the presence of a permanent stoma following APE
for rectal cancer [21].
A lower percentage of patients planned for palliative treat-
ment considered themselves well informed about their diag-
nosis and treatment plan compared with patients planned for
curative treatment. This indicates a need for improved com-
munication of palliative treatment, perhaps in a more struc-
tured manner [28, 40]. In this context, better support for the
surgeon may ultimately improve patient outcome [5].
QoLwas assessed by two global single questions pertaining
to Boverall^ and Bhealth-related^ QoL, respectively. While the
latter question concerns the patients’ self-rated health state, the
question on overall QoL relates also to other aspects of life that
may affect QoL. In view of this, it is interesting that patients
with a potentially curable disease differed from a normal pop-
ulation with regard to overall but not global health-related
QoL, meaning that their Bhealth state^ was not impaired by
the cancer but their general perception of QoL was.
Strengths of this study include the large patient cohort and
the inclusion of patients regardless of tumor stage. The partic-
ipation of university as well as county hospitals increases the
generalizability of results. Study hypotheses and a detailed
statistical analysis plan were decided on prior to data analyses.
The questionnaire was developed in a systematic way using
prevalidated questions as well as newly constructed disease-
specific questions validated according to accepted principles
[3, 6, 18, 36, 37]. The patients completed the questionnaire at
home and returned it to the coordinating center and not to the
treating hospital which may minimize bias [20].
Missing data were generally low. However, for global
health-related QoL, missing and/or invalid values were more
frequent, which we found to be partly explained by difficulties
for patients to correctly interpret instructions on how to fill out
their response on the EQ-5D-3L visual analogue scale. This
may potentially bias the results, but the direction and signifi-
cance of this bias are unclear.
Women were overrepresented among included compared
to non-included patients, but the sex distribution in the study
group was comparable to that reported for all new cases of
colorectal cancer in Europe 2012 [39]. Median age differed
Table 5 Association of planned treatment and intrusive thoughts with overall and global health-related QoL
Overall QoL Global health-related QoL (EQ-5D-3L VAS)
Low/moderatea (%) Highb (%) Comparison Odds 
ratiog
95 % CI Median (Q1;Q3)h Comparison p-value
All patients 733 (68) 339 (32) 79 (60;90)
Palliative 61 (84) 12 (16) Curative vs. palliative 0.56 0.36-0.88 53 (40;80) Curative vs. 
palliative
<0.001
Curative 672 (67) 327 (33) 80 (60;90)
Not APEc 478 (66) 252 (34) Not APE vs. APE 0.76 0.58-0.99 80 (62;90) Not APE vs. APE 0.080
APEd 194 (72) 75 (28) 75 (60;90)
Intrusive thoughts
No 76 (42) 103 (58) No vs. yes 0.33 0.24-0.45 85 (75;90) No vs. yes <0.001
Yes 646 (74) 232 (26) 75 (60;88)
Frequency  
Lowe 157 (58) 113 (42) Low vs. high 
frequency
0.43 0.32-0.57 80 (70;90) Low vs. high 
frequency
<0.001
Highe 489 (80) 119 (20) 70 (50;82)
Intrusiveness
Lowf 368 (67) 178 (33) Low vs. high 
intrusiveness
0.38 0.29-0.52 80 (61;90) Low vs. high 
intrusiveness
<0.001
Highf 235 (86) 37 (14) 69 (50;80)
Overall QoL is presented here as a dichotomized outcome (blue left columns), but the odds ratios for the comparisons between subgroups (pink left
columns) are based on the original seven-point Likert scale
a Zero to four on a seven-point Likert scale
b Five to six on a seven-point Likert scale
c Patients operated by other curative procedures than abdominoperineal excision
d Patients operated by abdominoperineal excision
e Less than once per week/at least once per week
f Less than moderately intrusive/moderately or very intrusive
gOdds ratio for a lower overall QoL, adjusted for age, sex, comorbidity, depression, occupation, education, marital status, sense of coherence, time from
diagnosis, and whether the patient regarded him or herself well informed about the cancer and planned treatment
h Data missing in 87 patients
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significantly between included and non-included patients, but
the 1-year difference is hardly of any clinical relevance in
relation to QoL. Included patients had a significantly lower
ASA grade, indicating that they were somewhat healthier than
non-included patients. Clinical tumor stage was significantly
lower in the study group. The differences in ASA grade and
clinical tumor stage between included and non-included pa-
tients must be considered in relation to the generalizability of
results, although the clinical relevance of the rather small dif-
ferences is difficult to determine.
A good understanding of Swedish or Danish was required
for participation, and thus, the results are not valid for patients
with little or no knowledge of these languages. Another lim-
itation of the study is that we did not have detailed informa-
tion on how the treatment plan was communicated to patients.
However, many participating departments of surgery and
caregivers may reduce the influence of differences in com-
munication and may reflect real life clinical practice at the
time.
Although efforts were made to recruit palliative patients to
the study, they seem somewhat underrepresented. However,
the classification of patients as curative or palliative was done
prospectively at the time of inclusion. As some patients ini-
tially scheduled for curative treatment were not operated, the
number of missed palliative patients may actually not be as
large as it looks. If a selection bias is present with regard to
patients planned for palliative treatment, it may lead to an
overestimation of QoL in this group.
Our results indicate that psychological factors need to be
considered as confounders in clinical studies that aim to de-
scribe quality of life. Furthermore, reducing intrusive thoughts
by way of a simple intervention like expressive writing [23]
may offer patients relief and possibly improve quality of life in
the face of a rectal cancer diagnosis.
The reported association of QoL and survival in patients
with cancer in general [9, 25, 31], and of pretreatment QoL
and survival in primary rectal cancer in particular [8], under-
pins the importance of our results. Furthermore, a survival
benefit of psychosocial intervention in patients with cancer
has been suggested [35]. However, whether efforts to improve
pretreatment QoL will translate into a better survival in pa-
tients with rectal cancer remains to be demonstrated.
We conclude that the QoL of Scandinavian patients who
had just received the treatment plan for their newly diagnosed
rectal cancer may be influenced by the presence of intrusive
thoughts and the patients’ sense of coherence as well as of the
intent of treatment. Future studies should evaluate the effect of
interventions aimed to improve QoL.
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